Advertisement
Home Tags Food & Drug Administration

Tag: Food & Drug Administration

The U.S. Food and Drug Administration has strengthened current warnings in the prescribing information about fluoroquinolone antibiotics causing significant decreases in blood glucose as well as mental health side effects.

FDA Requires Safety Label Changes for Fluoroquinolones

0
Changes will describe hypoglycemic coma and clarify and identify mental health side effects
High rates of Salmonella contamination have been identified in kratom products collected and tested since February 2018

High Rates of Salmonella Contamination ID’d in Kratom

0
As of end of May 2018, 199 cases of salmonellosis ID'd that were linked to kratom consumption
The U.S. Food and Drug Administration has permitted marketing of two catheter-based devices designed to create an arteriovenous fistula in patients with chronic kidney disease in need of hemodialysis.

FDA Permits Marketing of Devices to Create Arteriovenous Fistula

0
Two devices designed to create arteriovenous fistula in patients with CKD in need of hemodialysis
The U.S. Food and Drug Administration has approved Epidiolex oral solution for treatment of seizures associated with Lennox-Gastaut syndrome and Dravet syndrome for patients age 2 years and older.

FDA Approves Epidiolex for Severe Forms of Epilepsy

0
Cannabidiol oral solution approved for patients 2 and older with Lennox-Gastaut and Dravet syndromes
The Eversense Continuous Glucose Monitoring system

FDA Approves Continuous Glucose Monitoring System

0
Eversense CGM, which has fully implantable sensor to detect glucose, approved for adults with diabetes
Over the past two decades

Many Drugs Made Available Via FDA Expanded Access Programs

0
Half of meds ID'd in expanded access programs treat cancer; others for metabolic, endocrine diseases
The first generic version of an under-the-tongue film to treat opioid addiction has been approved by the U.S. Food and Drug Administration.

FDA Approves First Generic Under-the-Tongue Suboxone

0
May only be prescribed by Drug Addiction Treatment Act-certified prescribers
Nine online networks

FDA Warns Websites Marketing Unapproved Opioids

0
As part of comprehensive effort to target online sales, networks operating 53 sites received warnings
The first biosimilar drug to Neulasta has been approved by the U.S. Food and Drug Administration. Fulphila (pegfilgrastim) is approved for patients with non-myeloid cancer who are receiving myelosuppressive chemotherapy and have symptoms of febrile neutropenia.

FDA OKs 1st Biosimilar to Prevent Chemo-Related Infections

0
Fulphila, biosimilar to Neulasta, helps reduce risk of infection during cancer treatment
The first artificial iris has been approved by the U.S. Food and Drug Administration for patients with aniridia.

FDA Approves First Artificial Iris

0
CustomFlex Artificial Iris improves light sensitivity and glare, cosmetic appearance of the eye